Fighting Cancer Smarter: The Power of Data

Поділитися
Вставка
  • Опубліковано 2 чер 2024
  • Fighting Cancer Smarter: The Power of Data | TARGET: Cancer Podcast | Ep. 61
    Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
    - - - -TimeStamps - - - -
    00:00 Introduction
    07:38 The birth of Shepherd
    14:00 Shephard's approach to precision and tailored therapies
    17:10 The potential for cures in cancer treatment
    23:47 Genomic data to improve future treatments
    - - - -
    #cancertreatment #cancercure #medicine #precisiononcology
    🔴Like, Subscribe, and Share to see more of this type of content!
    - ABOUT DAVID HYSONG -
    David is the Founder and CEO at SHEPHERD. He is an ardent champion of patient rights and a defiantly human approach to healthcare. He founded SHEPHERD with vision and a mandate- to build something that would give freedom, power, and a defiant hope back to patients when they had had none, and give them options when they had nowhere left to turn. David was diagnosed at 27 with a rare form of head and neck cancer, Adenoid Cystic Carcinoma, while a graduate student at Harvard University. He had recently completed officer selection for special operations in the U.S. military and had previously worked in Southeast Asia against human trafficking and the sexual enslavement of children. He leveraged the same commitment to working for systemic change and to help those who suffer to build SHEPHERD alongside are markable team of people equally passionate about saving patients lives. David is a Forbes 30 Under 30 honoree, Aspen Institute Spotlight Health Scholar, and Charles River Research Models in Drug Discovery Award Recipient. He is a graduate of Harvard University, St. John’s College, and Transylvania University and is also the founder of The Billion Life Project, which seeks to create market-driven solutions to humanity’s greatest suffering; and Rage to LIVE, which seeks to inspire others to overcome their own limitations to do the impossible - on behalf of others.
    - ABOUT KATHERINE ARLINE -
    Katherine Arline leads the development of SHEPHERD’s products. She is a graduate of Harvard University, where she studied economics, quantitative analysis, molecular and cellular biology, and bioinformatics. Prior to her work at SHEPHERD, Katherine spent fifteen years working in technology. She was running a big data startup in the Harvard Innovation Lab when a close family member was diagnosed with a rare brain cancer. Katherine and David met one month later and she asked to join the company to leverage her background in technology, data, and entrepreneurship to benefit high-need cancer patients.
    - ABOUT DR SANJAY JUNEJA -
    Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
    He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
    - ABOUT xCURES -
    xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
    Learn more at: xcures.com/
    Facebook: / xcures.platform
    TikTok: / xcures.platform
    Instagram: / xcures.platform
    LinkedIn: / xcures
    Twitter: / xcures_platform
    TARGET: Cancer Podcast
    Homepage: xcures.com/target-cancer-podc...
    UA-cam: / targetcancer
    Spotify: open.spotify.com/show/2xMG5y5...
    iTunes: podcasts.apple.com/us/podcast...
    TuneIn:
    tunein.com/podcasts/Technolog...
    Google Podcasts:
    podcasts.google.com/feed/aHR0...
    Pandora:
    www.pandora.com/podcast/targe...
    Amazon Music:
    music.amazon.com/podcasts/a80...

КОМЕНТАРІ • 21

  • @TargetCancer
    @TargetCancer  Місяць тому +1

    To learn more about SHEPHERD Health, visit their website at www.shepherd.bio/

  • @Lilmodigly
    @Lilmodigly Місяць тому

    Thank you for the work you are all doing. I’m hopeful that this is the beginning of the answers we are all looking for.

  • @lisa-eg8nx
    @lisa-eg8nx Місяць тому

    Wow, again another very exciting interview for the future treatments of cancer. Thank you so much again for giving us such great hope❤

    • @TargetCancer
      @TargetCancer  Місяць тому

      We're glad you found the information helpful.

  • @blueridgemountainprepper2166
    @blueridgemountainprepper2166 Місяць тому +1

    I have cancer concerns, cant wait to watch this, thank u

  • @silvawade7127
    @silvawade7127 Місяць тому +1

    Great talk, it sounds so economical to treat a patient with this precision targeting of treatment

  • @user-fo2cc7xx4y
    @user-fo2cc7xx4y Місяць тому +2

    Can you talk about supplements such as quercetin that weaken the tumor prior to chemo(oxaliplatin) ,allwoing it to be more effective

    • @mpoharper
      @mpoharper Місяць тому +1

      Perhaps exogenous ketones!

  • @CancerOutsideTheBox
    @CancerOutsideTheBox Місяць тому

    Btw TY for your podcasts. Many are gems.

    • @TargetCancer
      @TargetCancer  Місяць тому +1

      Many thanks for your comment. We're glad you found the episodes helpful. Feel free to share the podcast with your contacts to help spread the knowledge.

  • @mpoharper
    @mpoharper Місяць тому +1

    I have no mutations that are currently targetable. My insurance company wouldn’t pay for it.

  • @CancerOutsideTheBox
    @CancerOutsideTheBox Місяць тому +1

    Stage IV rectal cancer here. Very broke, living, if you can call it that, on social security. I went to the Family Reach foundation mentioned and it looks like there's no money. Every single fund says "unavailable." Sigh.

    • @TargetCancer
      @TargetCancer  Місяць тому +1

      You can also check these options: www.cancer.net/navigating-cancer-care/financial-considerations/financial-resources
      Wishing you the best.

    • @elisamarro7356
      @elisamarro7356 26 днів тому

      ​@@TargetCancer if I live in Toronto ontario canada can I get the rna sequencing done from here via blood samples. Please provide details. Thanks

  • @lisa-eg8nx
    @lisa-eg8nx Місяць тому

    I would live to get a second opinion with you. Do you take zoom appts? I live in Illinois

    • @TargetCancer
      @TargetCancer  Місяць тому

      If you are asking about an appointment with Dr. Juneja, please visit: marybird.org/doctor/sjuneja/

    • @lisa-eg8nx
      @lisa-eg8nx Місяць тому

      Thank you!

  • @elisamarro7356
    @elisamarro7356 26 днів тому

    I live in Toronto ontario canada. Can I arrange for genome testing with you. Please advise. Elisa

    • @TargetCancer
      @TargetCancer  26 днів тому

      Please reach out to Shepherd Health on their website: www.shepherd.bio